What's Next for AIDS: New Approaches for Tackling HIV in the Developing World
The surprise success this summer of a clinical trial on an antiretroviral-based vaginal microbicide provides new traction for efforts to combat AIDS in the developing world. Here are some new directions to expect for treatment and prevention of this widespread killer
Staying Negative: How an Unexpected Antiretroviral Result Is Reshaping the Battle Against AIDS
Success of a vaginal microbicide gel reveals how HIV-prevention strategies can emerge from progress in treatment
A Failed "War on Drugs" Prompts Rethinking on HIV Infections among Injection-Drug Users
Drug policy has focused on a policing approach of prohibition and incarceration, which has contributed to spreading HIV within the injection-drug community. Comprehensive drug reform policies are showing better results...
Closeted Calamity: The Hidden HIV Epidemic of Men Who Have Sex with Men
A paucity of research on men who have sex with other men has done a disservice to efforts to prevent the spread of HIV

Renewed Hope for an AIDS Vaccine
Despite questions, the Thailand trial spreads optimism

Three Distinct Routes Detailed for How HIV Arises in Male Genital Tract
New research uncovers three methods of HIV development in the male genital tract that can make the virus look different from blood-borne populations

Antiretroviral regimens drastically reduce breast milk HIV transmission between mothers and babies
HIV infects an estimated 430,000 infants and children worldwide each year. Although many of those cases are contracted from an HIV-positive mother during pregnancy or birth, some 40 percent of infected children get the disease through breast-feeding...

Clean-Cut: Study Finds Circumcision Helps Prevent HIV and Other Infections
The first microbiome study of the penis offers some clues as to why removing foreskin cuts the risk of HIV infection in circumcised men

DNA Drugs Come of Age
After years of false starts, a new generation of DNA vaccines and medicines for HIV, influenza and other stubborn illnesses is now in clinical trials

U.S. global AIDS program slashes deaths but doesn't reduce HIV infections

HIV drugs could have second life as treatment for retrovirus correlated with prostate cancer

HIV genome structure decoded

Antibody Building: Does Training the Body's Immune System Hold a New Key to Fending Off HIV Infection?
NIH researchers may have found antibodies that can neutralize most varieties of HIV, blocking it before it infects healthy cells. But stimulating their sparse natural production remains a hurdle in developing an antiviral therapy...

Vaginal gel shows effectiveness in preventing HIV in women

Did Smallpox Vaccine Limit HIV?
The rise of HIV followed the cessation of widespread smallpox vaccination. A small study hints at a possible connection. Steve Mirsky reports

WHO's New Guidelines on HIV Care Call for Earlier Treatment
The new advice could make three to five million more people eligible to take antiretroviral drugs

Rise 'n Die, HIV: Strategies for a Cure Based on Waking the AIDS Virus
New weapons take aim at "latent reservoirs" by rousing the invader from its hiding spot in immune cells

Researchers Try to Solve the Mystery of HIV Carriers Who Don't Contract AIDS
Are "elite controllers" the key to understanding HIV infection—and do their immune systems offer a new approach to developing an AIDS vaccine?